Anagram Therapeutics Stock

Develops novel orally delivered enzyme replacement therapies to treat rare and serious diseases.

Buy

Buy Anagram Therapeutics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Anagram Therapeutics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Anagram Therapeutics is a biopharmaceutical company developing novel orally delivered enzyme replacement therapies to treat rare and serious diseases caused by malabsorption and nutrient metabolism disorders. Its primary focus is on conditions such as exocrine pancreatic insufficiency and cystic fibrosis, leveraging proprietary enzyme engineering and stabilization technologies to improve digestion and nutrient absorption where existing treatments are limited or inadequate.

Sector

Healthcare & Life Sciences

Founded

2019

Headquarters

Natick, MA

Anagram Therapeutics Funding

Anagram Therapeutics Funding History

Sign up to gain insights into Anagram Therapeutics funding history, including the funding round, time period, and amount raised.

Financing Round Date Amount Price per share Valuation
Round Date Amount PPS Valuation
Series D-4 Sep 29, 2025 50M
XXXXX
XXXXX
Series D-3 Sep 29, 2025 125M
XXXXX
XXXXX
Series D-1 Sep 29, 2025 75M
XXXXX
XXXXX
Series C Mar 30, 2023 12M
XXXXX
XXXXX
Series B Mar 30, 2023 7M
XXXXX
XXXXX
Series A Aug 22, 2019 17M
XXXXX
XXXXX

Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market

Buy

Buy Anagram Therapeutics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Anagram Therapeutics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Anagram Therapeutics Management Team

Anagram Therapeutics people and management

  • Co-Founder, CEO, President, Board Member
    Robert Gallotto
  • Board Member
    Aditya Karhade
  • Board Member
    Alexey Margolin
  • Board Member
    Andrew Miller
  • Board Member
    Colm Foley
  • Board Member
    Drucy Borowitz
  • Board Member
    Kiran Reddy
  • Board Member
    Preston Campbell
  • Board Member
    Robert K. Coughlin
  • Chief Medical Officer
    Evan Bailey

Investors

Major Anagram Therapeutics investors

  • Blackstone Group LP

Anagram Therapeutics Valuations & Financials

Gain Insights Into Anagram Therapeutics Stock Valuation & Share Prices

View real-time NPM data on Anagram Therapeutics stock including daily Anagram Therapeutics stock price estimates, valuation history, and historical share price information. Access Anagram Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Anagram Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Anagram Therapeutics? Get in touch to learn more.

Similar Companies

Explore companies

like Anagram Therapeutics

  • Noom Inc-Logo

    Noom

    Healthcare & Life Sciences

    Intelligent weight loss app.

  • Swordhealth-Logo

    Sword Health

    Healthcare & Life Sciences

    Virtual musculoskeletal care provider.

  • Clipboard Health-Logo

    Clipboard Health

    Healthcare & Life Sciences

    Uses technology to help nursing facilities get the right nurse at the right place at the right time.

  • Devoted Health

    Healthcare & Life Sciences

    Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

  • Capstan Medical

    Healthcare & Life Sciences

    Merges surgical robotics with catheter-based technology to repair and replace heart valves.

  • CareRev

    Healthcare & Life Sciences

    Healthcare staffing marketplace platform.

  • Loyal

    Healthcare & Life Sciences

    Develops therapies to treat the underlying causes of aging in dogs.

  • Q Bio

    Healthcare & Life Sciences

    Utilizes AI and continuous monitoring to provide personalized health insights for proactive well-being decisions.

  • Dragonfly Therapeutics

    Healthcare & Life Sciences

    Creates immune-based therapies designed to target and eliminate cancer cells.

FAQ

Questions?

We have answers

Buy Anagram Therapeutics Stock

Anagram Therapeutics stock does not trade on public stock exchanges. Anagram Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Anagram Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Anagram Therapeutics Stock

Anagram Therapeutics Stock does not trade on public stock exchanges. In order to sell Anagram Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Anagram Therapeutics Stock Price

Anagram Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Anagram Therapeutics share price and other valuable private market data.

Read more about secondary market private company stock prices:

Anagram Therapeutics Stock Ticker Symbol

There is no ticker symbol for Anagram Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Anagram Therapeutics Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Anagram Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Anagram Therapeutics Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Anagram Therapeutics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Anagram Therapeutics Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Anagram Therapeutics IPO

Anagram Therapeutics is a private company and has not had an IPO. There is currently no Anagram Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Anagram Therapeutics IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.